Changes in microRNA-1 expression and IK1 up-regulation in human atrial fibrillation

Heart Rhythm

Volumn 6, Issue 12, 2009, Pages 1802-1809

  Girmatsion, Zenawit ^a   Biliczki, Peter ^a   Bonauer, Angelika ^a   Wimmer Greinecker, Gerhard ^a   Scherer, Mirella ^a   Moritz, Anton ^a   Bukowska, Alicia ^b   Goette, Andreas ^b   Nattel, Stanley ^c   Hohnloser, Stefan H ^a   Ehrlich, Joachim R ^a  

^a GOETHE UNIVERSITY   (Germany)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

^c MONTREAL HEART INSTITUTE   (Canada)

Author keywords

atrial fibrillation; connexin; Inward rectifier potassium currents; microRNA

Indexed keywords

CONNEXIN 43; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR2.1; MESSENGER RNA; MICRORNA; MICRORNA 1; NUCLEIC ACID BINDING PROTEIN; PROTEIN I KAPPA 1; UNCLASSIFIED DRUG;

AGED; ARTICLE; BYPASS SURGERY; CONTROLLED STUDY; DOWN REGULATION; ELECTROPHYSIOLOGY; FEMALE; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIUM; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REPAIR; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SINUS RHYTHM; UPREGULATION;

ACTION POTENTIALS; AGED; ATRIAL FIBRILLATION; CONNEXINS; ELECTROPHYSIOLOGY; FEMALE; HEART ATRIA; HUMANS; ION CHANNEL GATING; MALE; MICRORNAS; POTASSIUM CHANNELS, INWARDLY RECTIFYING; UP-REGULATION;

EID: 70549111002     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2009.08.035     Document Type: Article

References (32)

1. Nattel S., Maguy A., Le Bouter S., and Yeh Y.H. Arrhythmogenic ion-channel remodelling in the heart: heart failure, myocardial infarction, and atrial fibrillation. Physiol Rev 87 (2007) 425-456
2. Burstein B., and Nattel S. Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. J Am Coll Cardiol 51 (2008) 802-809
3. Ehrlich J.R. Inward rectifier potassium currents as a target for atrial fibrillation therapy. J Cardiovasc Pharmacol 52 (2008) 129-135
4. Ehrlich J.R., Cha T.J., Zhang L., et al. Characterization of a hyperpolarization-activated time-dependent potassium current in canine cardiomyocytes from pulmonary vein myocardial sleeves and left atrium. J Physiol 557 (2004) 583-597
5. Bosch R.F., Zeng X., Grammer J.B., Popovic K., Mewis C., and Kuhlkamp V. Ionic mechanisms of electrical remodeling in human atrial fibrillation. Cardiovasc Res 44 (1999) 121-131
6. Dobrev D., Friedrich A., Voigt N., et al. The G protein-gated potassium current I(K,ACh) is constitutively active in patients with chronic atrial fibrillation. Circulation 112 (2005) 3697-3706
7. Pandit S.V., Berenfeld O., Anumonwo J.M., et al. Ionic determinants of functional reentry in a 2-D model of human atrial cells during simulated chronic atrial fibrillation. Biophys J 88 (2005) 3806-3821
8. Noujaim S.F., Pandit S.V., Berenfeld O., et al. Up-regulation of the inward rectifier K+ current (I K1) in the mouse heart accelerates and stabilizes rotors. J Physiol 578 (2007) 315-326
9. Xia M., Jin Q., Bendahhou S., et al. A Kir2.1 gain-of-function mutation underlies familial atrial fibrillation. Biochem Biophys Res Commun 332 (2005) 1012-1019
10. Schimpf R., Wolpert C., Gaita F., Giustetto C., and Borggrefe M. Short QT syndrome. Cardiovasc Res 67 (2005) 357-366
11. Yang B., Lin H., Xiao J., et al. The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat Med 13 (2007) 486-491
12. Yue L., Feng J., Li G.R., and Nattel S. Transient outward and delayed rectifier currents in canine atrium: properties and role of isolation methods. Am J Physiol 270 (1996) H2157-H2168
13. Bukowska A., Lendeckel U., Hirte D., et al. Activation of the calcineurin signaling pathway induces atrial hypertrophy during atrial fibrillation. Cell Mol Life Sci 63 (2006) 333-342
14. Goette A., Bukowska A., Lendeckel U., et al. Angiotensin II receptor blockade reduces tachycardia-induced atrial adhesion molecule expression. Circulation 117 (2008) 732-742
15. Guarnieri D.J., and DiLeone R.J. MicroRNAs: a new class of gene regulators. Ann Med 40 (2008) 197-208
16. Dobrev D., Graf E., Wettwer E., et al. Molecular basis of down-regulation of G-protein-coupled inward rectifying K(+) current (I(K,ACh) in chronic human atrial fibrillation: decrease in GIRK4 mRNA correlates with reduced I(K,ACh) and muscarinic receptor-mediated shortening of action potentials. Circulation 104 (2001) 2551-2557
17. Gaborit N., Steenman M., Lamirault G., et al. Human atrial ion channel and transporter subunit gene-expression remodeling associated with valvular heart disease and atrial fibrillation. Circulation 112 (2005) 471-481
18. Wright M., Haissaguerre M., Knecht S., et al. State of the art: catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol 19 (2008) 583-592
19. Sarmast F., Kolli A., Zaitsev A., et al. Cholinergic atrial fibrillation: I(K,ACh) gradients determine unequal left/right atrial frequencies and rotor dynamics. Cardiovasc Res 59 (2003) 863-873
20. Atienza F., Almendral J., Moreno J., et al. Activation of inward rectifier potassium channels accelerates atrial fibrillation in humans: evidence for a reentrant mechanism. Circulation 114 (2006) 2434-2442
21. Schram G., Pourrier M., Melnyk P., and Nattel S. Differential distribution of cardiac ion channel expression as a basis for regional specialization in electrical function. Circ Res 90 (2002) 939-950
22. Ehrlich J.R., Cha T.J., Zhang L., et al. Cellular electrophysiology of canine pulmonary vein cardiomyocytes: action potential and ionic current properties. J Physiol 551 (2003) 801-813
23. Cherry E.M., Ehrlich J.R., Nattel S., and Fenton F.H. Pulmonary vein reentry-properties and size matter: insights from a computational analysis. Heart Rhythm 4 (2007) 1553-1562
24. Pogwizd S.M., Schlotthauer K., Li L., and Bers D.M. Arrhythmogenesis and contractile dysfunction in heart failure: roles of sodium-calcium exchange, inward rectifier potassium current, and residual beta-adrenergic responsiveness. Circ Res 88 (2001) 1159-1167
25. Kanagaratnam P., Rothery S., Patel P., Severs N.J., and Peters N.S. Relative expression of immunolocalized connexins 40 and 43 correlates with human atrial conduction properties. J Am Coll Cardiol 39 (2002) 116-123
26. Davis L.M., Rodefeld M.E., Green K., Beyer E.C., and Saffitz J.E. Gap junction protein phenotypes of the human heart and conduction system. J Cardiovasc Electrophysiol 6 (1995) 813-822
27. Vozzi C., Dupont E., Coppen S.R., Yeh H.I., and Severs N.J. Chamber-related differences in connexin expression in the human heart. J Mol Cell Cardiol 31 (1999) 991-1003
28. Gollob M.H., Jones D.L., Krahn A.D., et al. Somatic mutations in the connexin 40 gene (GJA5) in atrial fibrillation. N Engl J Med 354 (2006) 2677-2688
29. Polontchouk L., Haefliger J.A., Ebelt B., et al. Effects of chronic atrial fibrillation on gap junction distribution in human and rat atria. J Am Coll Cardiol 38 (2001) 883-891
30. Wilhelm M., Kirste W., Kuly S., et al. Atrial distribution of connexin 40 and 43 in patients with intermittent, persistent, and postoperative atrial fibrillation. Heart Lung Circ 15 (2006) 30-37
31. Kostin S., Klein G., Szalay Z., Hein S., Bauer E.P., and Schaper J. Structural correlate of atrial fibrillation in human patients. Cardiovasc Res 54 (2002) 361-379
32. Kedde M., Strasser M.J., Boldajipour B., et al. RNA-binding protein Dnd1 inhibits microRNA access to target mRNA. Cell 131 (2007) 1273-1286